Hepatitis Foundation International   photo
The Good We Do Living with Hepatitis News and Research Support Education Donate Contact Us Home

 

Heplink Online Learning Center Subscribe to Our Newsletter E-Store

Clinical Trials Resource Center

About Research  |   Trials  |   NIH Trials  |   Email Notifications  |   FDA Approvals  |   Research Centers
Research Headlines  |   NMT Results  |   Bookstore


Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials


A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Georgia

Atlanta : Emory University Hospital Midtown

A clinical trial seeking patients for a research study for the treatment of Cardiac Catheter Ablation, Atrial Flutter or Cardiac Arrhythmias

Atlanta : Emory University Hospital

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Michigan

Lansing : Sparrow Clinical Research Institute

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

Lincoln : Bryan Heart

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

Columbus : The Ohio State University Medical Center

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

Wyomissing : Berks Cardiologists, Ltd.

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

Jackson : The Jackson Clinic, PA

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nashville : Vanderbilt University Medical Center

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Bulgaria

Sofia : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Varna : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Canada

London : London Health Sciences Center

A clinical trial to evaluate treatments using tricuspid isthmus imaging with Cartosound for patients with Atrial Flutter

France

Creteil : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Grenoble : CHU Grenoble

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Rennes : CHU de Rennes

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Rouen : University Hospital of Rouen

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Saint-etienne : CHU de Saint-Etienne

A clinical trial to evaluate treatments using Ramipril and Placebo for patients with Atrial Fibrillation or Atrial Flutter

Toulouse : Clinique Pasteur

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Germany

Rostock : Universitiy Medical Centre Rostock

A clinical research study of Antiarrhythmic drug, Cavo-tricuspid-isthmus-ablation and Pulmonary vein isolation for the treatment of Atrial Fibrillation or Atrial Flutter

Poland

Krakow : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lodz : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lublin : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Wroclaw : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Turkey

Istanbul : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Samsun : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Ukraine

Donetsk : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Kiev : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Uzhhorod : Updated

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

the good we do  |  living with hepatitis  |  news & research  |  support donate  |  contact us  |  site map  |   home

nnac  |  online learning center  |  subscribe to our newsletter   |   disclaimer  |  privacy

 

 

Hepatitis Foundation International
(800) 891-0707
HFI@comcast.net

©2003. All rights reserved.